I referred a patient to see an ophthalmologist after seeing lattice degeneration in the fundus. I received a letter back from the consultant at University Hospital Birmingham saying that he did not see the patient as there is no indication that treatment of lattice degeneration in any way prevents the likelihood of retinal detachment.
I have referred six people with a similar condition last year and they have either been lasered (for prophylaxis), monitored, or referred back to me for regular monitoring. In contrast, they were referred to the Wolverhampton Eye Infirmary (at least they had the decency to see the patients).
Can anyone shed light on this matter as I do not want to refer patients if it is a waste of time to do so?
Prem Kora
 I hope readers found something of interest in the brief introduction to the history, applications and materials production of intraocular lenses (IOLs) published in optician (June 10).
To give this introductory article added credence, the author was in fact Richard Young, PhD, head of our research team here at Contamac Group headquarters.
In addition to our work as contact lens materials specialists, we have some 15 years' experience in developing and producing IOL materials, working closely with manufacturers and IOL designers worldwide to contribute to the advancement of the sector in cataract management.
The latest generation of Contamac materials will, for example, be on show at the annual congress exhibition of the European Society of Cataract and Refractive Surgeons in Lisbon in September, where optician readers would be welcomed by the Contamac team attending the event.
Steve Wheeler
Group Marketing Director, Contamac

 Moneo is mistaken (optician, June 10 2005) in saying that optometrists were not offered the chance to have an NHS pension.
When the NHS started we were given the choice of a higher sight test fee or pension. This is the reason we are paid more than OMPs. The extra is for our pension. Unfortunately, we got it wrong.
JB Richards